Jensen, J.U., Lundgren, B., Hein, L., Mohr, T., Petersen, P.L., Andersen, L.H., Lauritsen, A.O., Hougaard, S., Mantoni, T., Bomler, B., Thornberg, K.J., Thormar, K., Loken, J., Steensen, M., Carl, P., Petersen, J.A., Tousi, H., Soe-Jensen, P., Bestle, M., Hestad, S., Andersen, M.H., Fjeldborg, P., Larsen, K.M., Rossau, C., Thomsen, C.B., et al. (2008) The Procalcitonin And Survival Study (PASS)-A Randomised Multi-Center Investigator-Initiated Trial to Investigate whether Daily Measurements Biomarker Procalcitonin and Pro-Active Diagnostic and Therapeutic Responses to Abnormal Procalcitonin Levels, Can Improve Survival in Intensive Care unit Patients. Calculated Sample Size (Target Population): 1000 Patients. BMC Infectious Diseases, 8, 91. http://dx.doi.org/10.1186/1471-2334-8-91

has been cited by the following article: